Home › Funds › Royce & Associates › NGVT
Royce & Associates position in NGVT
INGEVITY CORP · Industrials
Royce & Associates reported holding 863,539 shares of NGVT (INGEVITY CORP) in its Q3 2026 13F filing — a position valued at US$61.1M, representing 0.56% of its reported portfolio and ranking #23 among its reported holdings. Royce & Associates has disclosed NGVT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Royce & Associates's NGVT position evolved
Royce & Associates first disclosed a stake in NGVT in Q3 2023 at 254,009 shares (US$12.1M). The position peaked in Q2 2026 at 940,417 shares, worth US$70.2M. Across 13 filings, Royce & Associates increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 863,539 shares valued at US$61.1M — a reduction of -76,878 shares quarter over quarter.. Notable position changes include a 160% increase in Q4 2023 (shares rose 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 254.01K | $12.09M | New |
| Q4 2023 | 660.94K | $31.21M | Add |
| Q1 2024 | 717.55K | $34.23M | Add |
| Q2 2024 | 757.23K | $33.10M | Add |
| Q3 2024 | 933.68K | $36.41M | Add |
| Q4 2024 | 1.14M | $46.56M | Add |
| Q1 2025 | 1.21M | $47.84M | Add |
| Q2 2025 | 1.10M | $47.37M | Reduce |
| Q3 2025 | 1.03M | $56.96M | Reduce |
| Q4 2025 | 1.11M | $65.76M | Add |
| Q1 2026 | 883.53K | $62.93M | Reduce |
| Q2 2026 | 940.42K | $70.22M | Add |
| Q3 2026 | 863.54K | $61.10M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NGVT and 13F data
NGVT (INGEVITY CORP) is a Industrials company. 33 other funds we track also report a position in NGVT — the largest reported positions include SEGALL BRYANT & HAMILL, LLC (US$71.4M), ROYCE & ASSOCIATES LP (US$61.1M), Harvey Partners, LLC (US$56.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NGVT
- SEGALL BRYANT & HAMILL, LLC 1.01M sh · $71.38M · Q3 2026
- ROYCE & ASSOCIATES LP 863.54K sh · $61.10M · Q3 2026
- Harvey Partners, LLC 797.50K sh · $56.42M · Q3 2026
- Simcoe Capital Management, LLC 712.38K sh · $50.40M · Q3 2026
- Maple Rock Capital Partners Inc. 603.30K sh · $42.68M · Q3 2026
- Vision One Management Partners, LP 535.49K sh · $37.89M · Q3 2026
More on Royce & Associates
FAQ
How long has Royce & Associates held NGVT?
Royce & Associates has disclosed NGVT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Royce & Associates's current position in NGVT?
As of Q3 2026, Royce & Associates holds 863.54K shares of NGVT (INGEVITY CORP), valued at $61.10M, representing 0.56% of its reported portfolio and ranking #23.
Has Royce & Associates been buying or selling NGVT?
In the latest 13F filing (Q3 2026), Royce & Associates reduced its position in NGVT. The position peaked in Q2 2026 at 940.42K shares.
Which other funds hold NGVT?
Other major institutional holders of NGVT include SEGALL BRYANT & HAMILL, LLC, ROYCE & ASSOCIATES LP, Harvey Partners, LLC, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.